Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab

The treatment of advanced non-small cell lung cancer (NSCLC) has been revolutionized by immune checkpoint inhibitors (ICIs). The identification of prognostic and predictive factors in ICIs-treated patients is presently challenging. Circulating tumor cells (CTCs) and cell-free DNA (cfDNA) were evalua...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Alama, Angela, Coco, Simona, Genova, Carlo, Rossi, Giovanni, Fontana, Vincenzo, Tagliamento, Marco, Dal Bello, Maria Giovanna, Rosa, Alessandra, Boccardo, Simona, Rijavec, Erika, Biello, Federica, Longo, Luca, Cavalieri, Zita, Bruzzo, Cristina, Grossi, Francesco
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6679117/
https://ncbi.nlm.nih.gov/pubmed/31295929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8071011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars